Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac.
Adaptive radiotherapy
Bladder cancer
MR-guided radiotherapy
MR-linac
Journal
Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
07
03
2022
revised:
21
04
2022
accepted:
24
04
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
Bladder tumour-focused magnetic resonance image-guided adaptive radiotherapy using a 1.5 Tesla MR-linac is feasible. A full online workflow adapting to anatomy at each fraction is achievable in approximately 30 min. Intra-fraction bladder filling did not compromise target coverage with the class solution employed.
Identifiants
pubmed: 35571274
doi: 10.1016/j.ctro.2022.04.008
pii: S2405-6308(22)00031-3
pmc: PMC9092067
doi:
Types de publication
Journal Article
Langues
eng
Pagination
27-32Informations de copyright
© 2022 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
Déclaration de conflit d'intérêts
The Royal Marsden Hospital, and The Institute of Cancer Research are members of the Elekta MR-linac Consortium, which aims to coordinate international collaborative research relating to the Elekta Unity (MR-linac). Elekta (Elekta AB, Stockholm, Sweden) and Philips (Philips, Best, Netherlands) are commercial members of the MR-linac Consortium. Elekta financially supports consortium member institutions with research funding, education, and travel costs for consortium meetings. S.H. is bladder tumour site group lead within the MR-linac Consortium. No commercial financial support was received from any organisation for the submitted work.
Références
Clin Oncol (R Coll Radiol). 2021 Jun;33(6):350-368
pubmed: 33972024
Clin Transl Radiat Oncol. 2020 Sep 11;25:46-51
pubmed: 33015380
Radiother Oncol. 2019 Dec;141:130-136
pubmed: 31630869
Clin Transl Radiat Oncol. 2021 Apr 16;29:9-10
pubmed: 34027138
Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1022-30
pubmed: 27026308
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):197-207
pubmed: 15093917
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9
pubmed: 23958147
Radiother Oncol. 2013 Dec;109(3):457-62
pubmed: 24100147
Front Oncol. 2021 Feb 25;11:637591
pubmed: 33718230
Clin Transl Radiat Oncol. 2019 Apr 02;18:54-59
pubmed: 31341976
Clin Oncol (R Coll Radiol). 2018 Nov;30(11):711-719
pubmed: 30201276
Radiother Oncol. 2016 Jan;118(1):154-9
pubmed: 26631646
Phys Med Biol. 2011 Aug 21;56(16):5119-29
pubmed: 21775790
BMJ Open. 2020 Dec 31;10(12):e041005
pubmed: 33384390
Clin Oncol (R Coll Radiol). 2021 Jun;33(6):e251-e256
pubmed: 33766502
Radiother Oncol. 2021 Jun;159:146-154
pubmed: 33775715
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):115-122
pubmed: 28586948